Dominion Diamond Corp  

(Public, NYSE:DDC)   Watch this stock  
Find more results for NYSE:HWD
+0.09 (0.71%)
Mar 24 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 12.60 - 12.76
52 week 7.92 - 12.88
Open 12.63
Vol / Avg. 577,496.00/646,399.00
Mkt cap 1.06B
P/E     -
Div/yield 0.20/3.14
EPS -0.39
Shares 83.06M
Beta 0.62
Inst. own 68%

Key stats and ratios

Q4 (Oct '16) 2016
Net profit margin 24.74% -5.38%
Operating margin -8.87% 1.11%
EBITD margin - 31.75%
Return on average assets 4.93% -1.72%
Return on average equity 9.42% -2.57%
Employees 1,527 -
CDP Score - -


1102-4920 52 St
+1-867-6696100 (Phone)
+1-867-6699293 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Dominion Diamond Corp is a diamond mining company. The Company is focused on the mining and marketing of rough diamonds to the global market. The Company's segments include the Ekati Diamond Mine, the Diavik Diamond Mine and the Corporate segment. It supplies rough diamonds to the global market from its operation of the Ekati Diamond Mine (in which it owns a controlling interest) and its approximately 40% ownership interest in the Diavik Diamond Mine. It controls the Ekati Diamond Mine, as well as the associated diamond sorting and sales facilities in Toronto and Yellowknife, Canada, Mumbai, India, and Antwerp, Belgium. The Ekati Diamond Mine consists of the Core Zone, which includes the operating mine and other permitted kimberlite pipes, as well as the Buffer Zone, an adjacent area hosting kimberlite pipes having both development and exploration potential, such as the Jay kimberlite pipe and the Lynx kimberlite pipe.

Officers and directors

Brendan Bell Director
Age: 44
Bio & Compensation  - Reuters
Matthew Dennis Allen Quinlan Chief Financial Officer
Bio & Compensation  - Reuters
Chantal Lavoie Chief Operating Officer
Bio & Compensation  - Reuters
James R.W. Pounds Executive Vice President - Diamonds
Bio & Compensation  - Reuters
Elliot Holland Vice President - Projects
Bio & Compensation  - Reuters
James K. Gowans Non-Executive Independent Chairman of the Board
Age: 64
Bio & Compensation  - Reuters
Trudy M. Curran Director
Age: 54
Bio & Compensation  - Reuters
Tim Dabson Director
Bio & Compensation  - Reuters
Robert A. Gannicott Director
Age: 68
Bio & Compensation  - Reuters
Graham G. Clow Independent Director
Age: 65
Bio & Compensation  - Reuters